These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 14733590
21. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model. Rollman E, Mathy N, Bråve A, Boberg A, Kjerrström A, van Wely C, Engström G, Johansson S, Aperia K, Eriksson LE, Benthin R, Ertl P, Heeney J, Hinkula J, Voss G, Wahren B. Vaccine; 2007 Mar 01; 25(11):2145-54. PubMed ID: 17254672 [Abstract] [Full Text] [Related]
22. Hemagglutinating virus of Japan protein is efficient for induction of CD4+ T-cell response by a hepatitis B core particle-based HIV vaccine. Takeda S, Shiosaki K, Kaneda Y, Nakasatomi T, Yoshizaki H, Someya K, Konno Y, Eda Y, Kino Y, Yamamoto N, Honda M. Clin Immunol; 2004 Jul 01; 112(1):92-105. PubMed ID: 15207786 [Abstract] [Full Text] [Related]
23. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef. Thakar MR, Bhonge LS, Lakhashe SK, Shankarkumar U, Sane SS, Kulkarni SS, Mahajan BA, Paranjape RS. J Infect Dis; 2005 Sep 01; 192(5):749-59. PubMed ID: 16088824 [Abstract] [Full Text] [Related]
24. Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidates. Abdel-Aal AB, Batzloff MR, Fujita Y, Barozzi N, Faria A, Simerska P, Moyle PM, Good MF, Toth I. J Med Chem; 2008 Jan 10; 51(1):167-72. PubMed ID: 18072728 [Abstract] [Full Text] [Related]
25. Synthetic peptide vaccine development: measurement of polyclonal antibody affinity and cross-reactivity using a new peptide capture and release system for surface plasmon resonance spectroscopy. Cachia PJ, Kao DJ, Hodges RS. J Mol Recognit; 2004 Jan 10; 17(6):540-57. PubMed ID: 15386623 [Abstract] [Full Text] [Related]
26. Polarity of immunogens: implications for vaccine design. Golvano J, Lasarte JJ, Sarobe P, Gullón A, Prieto J, Borrás-Cuesta F. Eur J Immunol; 1990 Oct 10; 20(10):2363-6. PubMed ID: 1700756 [Abstract] [Full Text] [Related]
27. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B. Yu S, Feng X, Shu T, Matano T, Hasegawa M, Wang X, Ma H, Li H, Li Z, Zeng Y. Vaccine; 2008 Nov 11; 26(48):6124-31. PubMed ID: 18812199 [Abstract] [Full Text] [Related]
28. Sequential priming and boosting with heterologous HIV immunogens predominantly stimulated T cell immunity against conserved epitopes. Xu J, Ren L, Huang X, Qiu C, Liu Y, Liu Y, Shao Y. AIDS; 2006 Nov 28; 20(18):2293-303. PubMed ID: 17117015 [Abstract] [Full Text] [Related]
29. Influence of polypeptide size and intracellular sorting on the induction of epitope-specific CTL responses by DNA vaccines in a mouse model. Wild J, Bojak A, Deml L, Wagner R. Vaccine; 2004 Apr 16; 22(13-14):1732-43. PubMed ID: 15068857 [Abstract] [Full Text] [Related]
30. A peptide carrier with a built-in vaccine adjuvant: construction of immunogenic conjugates. Krikorian D, Panou-Pomonis E, Voitharou C, Sakarellos C, Sakarellos-Daitsiotis M. Bioconjug Chem; 2005 Apr 16; 16(4):812-9. PubMed ID: 16029022 [Abstract] [Full Text] [Related]
31. Fully synthetic immunogens. Part III. Synthesis of hinge-peptide/gastrin conjugates and their immunological properties. Wünsch E, Moroder L, Hübener G, Musiol HJ, Von Grünigen R, Göhring W, Scharf R, Schneider CH. Int J Pept Protein Res; 1991 Feb 16; 37(2):90-102. PubMed ID: 1708369 [Abstract] [Full Text] [Related]
33. Immunogenecity of synthetic peptides representing linear B-cell epitopes of VapA of Rhodococcus equi. Taouji S, Nomura I, Giguère S, Tomomitsu S, Kakuda T, Ganne V, Takaï S. Vaccine; 2004 Mar 12; 22(9-10):1114-23. PubMed ID: 15003638 [Abstract] [Full Text] [Related]
34. Helminth infection suppresses T-cell immune response to HIV-DNA-based vaccine in mice. Da'Dara AA, Lautsch N, Dudek T, Novitsky V, Lee TH, Essex M, Harn DA. Vaccine; 2006 Jun 12; 24(24):5211-9. PubMed ID: 16675073 [Abstract] [Full Text] [Related]
35. HIV-1 peptide vaccine candidates: selecting constrained V3 peptides with highest affinity to antibody 447-52D. Mester B, Manor R, Mor A, Arshava B, Rosen O, Ding FX, Naider F, Anglister J. Biochemistry; 2009 Aug 25; 48(33):7867-77. PubMed ID: 19552398 [Abstract] [Full Text] [Related]
36. The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope. Benferhat R, Martinon F, Krust B, Le Grand R, Hovanessian AG. Mol Immunol; 2009 Feb 25; 46(4):705-12. PubMed ID: 19010547 [Abstract] [Full Text] [Related]
37. Totally synthetic peptide-based immunocontraceptive vaccines show activity in dogs of different breeds. Walker J, Ghosh S, Pagnon J, Colantoni C, Newbold A, Zeng W, Jackson DC. Vaccine; 2007 Oct 10; 25(41):7111-9. PubMed ID: 17825958 [Abstract] [Full Text] [Related]
38. Immune response induced by a different combined immunization of HBsAg vaccine. Wu T, Chen M, Ou SH, Cheng T, Zhang J, Xia NS. Intervirology; 2007 Oct 10; 50(5):336-40. PubMed ID: 17700028 [Abstract] [Full Text] [Related]
39. Synthesis and in vitro T-cell immunogenicity of conjugates with dual specificity: attachment of epitope peptides of 16 and 38 kDa proteins from Mycobacterium tuberculosis to branched polypeptide. Wilkinson KA, Vordermeier H, Wilkinson RJ, Ivanyi J, Hudecz F. Bioconjug Chem; 1998 Oct 10; 9(5):539-47. PubMed ID: 9736487 [Abstract] [Full Text] [Related]
40. Efficient expansion of HIV-1-specific T cell responses by homologous immunization with recombinant Semliki Forest virus particles. Sundbäck M, Douagi I, Dayaraj C, Forsell MN, Nordström EK, McInerney GM, Spångberg K, Tjäder L, Bonin E, Sundström M, Liljeström P, Karlsson Hedestam GB. Virology; 2005 Oct 25; 341(2):190-202. PubMed ID: 16098555 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]